SESN2 expression is higher in endometrial cancer tissues than normal endometrial tissues, and its knockdown stimulated endometrial cancer cell proliferation and tumor growth in vivo, as observed in a mouse xenograft model. This evidence concerns the gene SESN2 and neoplasm.